Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-4.00	-500.76	-481.51
Graham Fair Price	0.00	2.09	2.09
PEG	inf	0.00	-0.04
Price/Book	4.37	0.95	0.91
Price/Cash Flow	-4.37	-1043.62	-999.93
Prices/Earnings	4.37	6.29	6.03
Price/Sales	4.37	21.78	20.86
Price/FCF	-4.37	-1043.62	-999.93
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	0.00	0.94	0.94
ROA	0.00	0.03	0.03
ROE	0.04	0.04	0.00
ROIC	0.04	0.03	-8.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	0.26	inf
Dividends QOQ	< 0.005	0.00	inf
EBIT QOQ	1.84	0.00	inf
EPS QOQ	1.71	0.00	inf
FCF QOQ	-1.01	0.00	inf
Revenue QOQ	1.95	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	95.82	100.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.09	0.16	83.82
Quick Ratio	0.10	0.49	390.55
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	2.26	2.26	0.00
Cash	0.03	0.03	0.00
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	0.00
Revenue	0.10	0.10	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.49	0.49	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-40.96	-40.96	0.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating